F.W. Hoff

E-mail:
f.w.hoff umcg.nl
Research
1 - 14 out of 14Page size: 50
- 2020
- Hoff, F. W., van Dijk, A. D., Qiu, Y. H., Ruvolo, P. P., Gerbing, R. B., Leonti, A. R., Jenkins, G. N., Gamis, A. S., Aplenc, R., Kolb, E. A., Alonzo, T., Meshinchi, S., De Bont, E., Bruggeman, S. W., Kornblau, S. M., & Horton, T. M. (2020). Heat Shock Factor 1 (HSF1-pSer326) Predicts Response to Bortezomib-Containing Chemotherapy in Pediatric AML: A COG Study. Blood. https://doi.org/10.1182/blood.2020005208
- Mirali, S., Botham, A., Voisin, V., Xu, C., St-Germain, J., Sharon, D., Hoff, F. W., Qiu, Y., Hurren, R., Gronda, M., Jitkova, Y., Nachmias, B., MacLean, N., Wang, X., Arruda, A., Minden, M. D., Horton, T. M., Kornblau, S. M., Chan, S. M., ... Schimmer, A. D. (2020). The mitochondrial peptidase, neurolysin, regulates respiratory chain supercomplex formation and is necessary for AML viability. Science Translational Medicine, 12(538), [8264]. https://doi.org/10.1126/scitranslmed.aaz8264
- 2019
- Hoff, F. W., Hu, C. W., Qutub, A. A., Qiu, Y., Hornbaker, M. J., Bueso-Ramos, C., Abbas, H. A., Post, S. M., de Bont, E. S. J. M., & Kornblau, S. M. (2019). Proteomic Profiling of Acute Promyelocytic Leukemia Identifies Two Protein Signatures Associated with Relapse. Proteomics. Clinical Applications, 13(4), [1800133]. https://doi.org/10.1002/prca.201800133
- Hoff, F. W., Lu, Y., & Kornblau, S. M. (2019). Antibody Screening. In T. Yamada, SS. Nishizuka, GB. Mills, & LA. Liotta (Eds.), Reverse phase protein arrays: from technical and analytical fundamentals to applications (Vol. 1188, pp. 149-163). (Advances in Experimental Medicine and Biology; Vol. 1188). Springer International Publishing AG. https://doi.org/10.1007/978-981-32-9755-5_8
- Hoff, F. W., Dijk, van, A. D., & Kornblau, S. M. (2019). Proteoforms in Acute Leukemia: Evaluation of Age- and Disease-Specific Proteoform Patterns. In X. Zhan (Ed.), Proteoforms (pp. 62-79). IntechOpen. https://doi.org/10.5772/intechopen.83687
- Dijk, van, A., Hoff, F., & Kornblau, S. M. (2019). Proteomics in Acute Myeloid Leukemia: Guidance to Targeted Therapy Selection and Risk Stratification. In Proteomics: Advances in Research and Applications (pp. 1-38). (Systems Biology – Theory, Techniques and Applications). Nova Science Publishers. https://ebookcentral.proquest.com/lib/rug/reader.action?docID=5981529&ppg=13
- 2018
- Hoff, F. W., Hu, C. W., Qutub, A. A., Qiu, Y., Graver, E., Hoang, G., Chauhan, M., de Bont, E. S. J. M., & Kornblau, S. M. (2018). Mycoplasma contamination of leukemic cell lines alters protein expression determined by reverse phase protein arrays. Cytotechnology, 70(6), 1529-1535. https://doi.org/10.1007/s10616-018-0244-2
- Hoff, F. W., Hu, W., Qiu, Y., Gamis, A. S., Aplenc, R., Kolb, E. A., Alonzo, T. A., Qutub, A. A., de Bont, E. S., Bruggeman, S. W. M., Kornblau, S. M., & Horton, T. M. (2018). RPPA-Profiling Identifies Patients with Low Phosphorylation Levels of HSF1 at Serine 326 As Potential Candidate for Bortezomib Treatment in Addition to Standard Therapy in Pediatric Acute Myeloid Leukemia. Blood, 132(Suppl.1). https://doi.org/10.1182/blood-2018-99-110730
- Hoff, F. W., Hu, C. W., Qiu, Y., Ligeralde, A., Yoo, S-Y., Mahmud, H., de Bont, E. S. J. M., Qutub, A. A., Horton, T. M., & Kornblau, S. M. (2018). Recognition of Recurrent Protein Expression Patterns in Pediatric Acute Myeloid Leukemia Identified New Therapeutic Targets. Molecular Cancer Research, 16(8), 1275-1286. https://doi.org/10.1158/1541-7786.MCR-17-0731
- Hoff, F. W., Hu, C. W., Qiu, Y., Ligeralde, A., Yoo, S-Y., Scheurer, M. E., de Bont, E. S. J. M., Qutub, A. A., Kornblau, S. M., & Horton, T. M. (2018). Recurrent Patterns of Protein Expression Signatures in Pediatric Acute Lymphoblastic Leukemia: Recognition and Therapeutic Guidance. Molecular Cancer Research, 16(8), 1263-1274. https://doi.org/10.1158/1541-7786.MCR-17-0730
- van Dijk, A. D., Hu, C. W., de Bont, E. S. J. M., Qiu, Y., Hoff, F. W., Yoo, S. Y., Coombes, K. R., Qutub, A. A., & Kornblau, S. M. (2018). Histone Modification Patterns Using RPPA-Based Profiling Predict Outcome in Acute Myeloid Leukemia Patients. Proteomics, 18(8), [1700379]. https://doi.org/10.1002/pmic.201700379
- Hoff, F. W., Hu, C. W., Qutub, A. A., de Bont, E. S. J. M., Horton, T. M., & Kornblau, S. M. (2018). Shining a light on cell signaling in leukemia through proteomics: Relevance for the clinic. Expert review of proteomics, 15(7), 613-622. https://doi.org/10.1080/14789450.2018.1487781
- 2017
- de Bruijn, C. M. A., Hoff, F. W., Bruggeman-Westermann, M. M., Terra, J. B., van Dijk, T. H., de Bont, E. S. J. M., & Peek, A. M. L. (2017). Optimizing VAP scars after childhood cancer treatment: A pilot study. Supportive Care in Cancer, 25(12), 3651-3654. https://doi.org/10.1007/s00520-017-3787-4
- Schultz, A., Mehta, S., Hu, C. W., Hoff, F. W., Horton, T. M., Kornblau, S. M., & Qutub, A. A. (2017). Identifying cancer specific metabolic signatures using constraint-based models. Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing, 22, 485-496. https://doi.org/10.1142/9789813207813_0045
ID: 15549699